{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:40:21Z","timestamp":1794008421333,"version":"4.8.0"},"reference-count":21,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Severe and critical COVID-19 pneumonia can lead to long-term complications, especially affecting pulmonary function and immune health. However, the extent and progression of these complications over time are not well understood. This study aimed to assess lung function, radiological changes, and some immune parameters in survivors of severe and critical COVID-19 up to 12 months after hospital discharge. Materials and Methods: This prospective observational cohort study followed 85 adult patients who were hospitalized with severe or critical COVID-19 pneumonia at a tertiary care hospital in Vilnius, Lithuania, for 12 months post-discharge. Pulmonary function tests (PFTs), including forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), and diffusion capacity for carbon monoxide (DLCO), were conducted at 3, 6, and 12 months. High-resolution chest computed tomography (CT) scans assessed residual inflammatory and profibrotic\/fibrotic abnormalities. Lymphocyte subpopulations were evaluated via flow cytometry during follow-up visits to monitor immune status. Results: The median age of the cohort was 59 years (IQR: 51\u201364). Fifty-three (62.4%) patients had critical COVID-19 disease. Pulmonary function improved significantly over time, with increases in FVC, FEV1, VC, TLC, and DLCO. Residual volume (RV) did not change significantly over time, suggesting that some aspects of lung function, such as air trapping, remained stable and may require attention in follow-up care. The percentage of patients with restrictive spirometry patterns decreased from 24.71% at 3 months to 14.8% at 12 months (p &lt; 0.05). Residual inflammatory changes on CT were present in 77.63% at 6 months, decreasing to 69.62% at 12 months (p &lt; 0.001). Profibrotic changes remained prevalent, affecting 82.89% of patients at 6 months and 73.08% at 12 months. Lymphocyte counts declined significantly from 3 to 12 months (2077 cells\/\u00b5L vs. 1845 cells\/\u00b5L, p = 0.034), with notable reductions in CD3+ (p = 0.040), CD8+ (p = 0.007), and activated CD3HLA-DR+ cells (p &lt; 0.001). This study found that higher CD4+ T cell counts were associated with worse lung function, particularly reduced total lung capacity (TLC), while higher CD8+ T cell levels were linked to improved pulmonary outcomes, such as increased forced vital capacity (FVC) and vital capacity (VC). Multivariable regression analyses revealed that increased levels of CD4+\/CD28+\/CD192+ T cells were associated with worsening lung function, while higher CD8+\/CD28+\/CD192+ T cell counts were linked to better pulmonary outcomes, indicating that immune dysregulation plays a critical role in long-term respiratory recovery. Conclusions: Survivors of severe and critical COVID-19 pneumonia continue to experience significant long-term impairments in lung function and immune system health. Regular monitoring of pulmonary function, radiological changes, and immune parameters is essential for guiding personalized post-COVID-19 care and improving long-term outcomes. Further research is needed to explore the mechanisms behind these complications and to develop targeted interventions for long COVID-19.<\/jats:p>","DOI":"10.3390\/medicina60121954","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T07:18:42Z","timestamp":1732691922000},"page":"1954","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-Term Pulmonary Sequelae and Immunological Markers in Patients Recovering from Severe and Critical COVID-19 Pneumonia: A Comprehensive Follow-Up Study"],"prefix":"10.3390","volume":"60","author":[{"given":"Edita","family":"Strumiliene","sequence":"first","affiliation":[{"name":"Clinic of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, 01513 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgita","family":"Urbonien\u0117","sequence":"additional","affiliation":[{"name":"Centre of Infectious Diseases, Vilnius University Hospital Santaros klinikos, 08661 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laimute","family":"Jurgauskiene","sequence":"additional","affiliation":[{"name":"Clinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, 01513 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrida","family":"Zeleckiene","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nuclear Medicine and Medical Physics, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, 01513 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rytis","family":"Bliudzius","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nuclear Medicine and Medical Physics, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, 01513 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3255-7669","authenticated-orcid":false,"given":"Laura","family":"Malinauskiene","sequence":"additional","affiliation":[{"name":"Clinic of Chest Diseases, Immunology and Allergology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, 01513 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birut\u0117","family":"Zablockiene","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, 01513 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturas","family":"Samuilis","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nuclear Medicine and Medical Physics, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, 01513 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6488-6312","authenticated-orcid":false,"given":"Ligita","family":"Jancoriene","sequence":"additional","affiliation":[{"name":"Clinic of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, 01513 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent Symptoms in Patients After Acute COVID-19","volume":"324","author":"Carfi","year":"2020","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: A cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/thoraxjnl-2021-217031","article-title":"Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length","volume":"76","author":"McGroder","year":"2021","journal-title":"Thorax"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"E383","DOI":"10.1148\/radiol.2021211396","article-title":"CT of Post-Acute Lung Complications of COVID-19","volume":"301","author":"Solomon","year":"2021","journal-title":"Radiology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101401","DOI":"10.1016\/j.beha.2022.101401","article-title":"COVID-19 disease and immune dysregulation","volume":"35","author":"Davitt","year":"2022","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_6","unstructured":"WHO (2020, March 13). Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease Is Suspected: Interim Guidance. Available online: https:\/\/iris.who.int\/handle\/10665\/331446."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1148\/radiol.2020200230","article-title":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)","volume":"295","author":"Chung","year":"2020","journal-title":"Radiology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1148\/radiol.2283030726","article-title":"Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: Preliminary experience","volume":"228","author":"Antonio","year":"2003","journal-title":"Radiology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12519-023-00765-z","article-title":"Risk factors for long COVID in children and adolescents: A systematic review and meta-analysis","volume":"20","author":"Rayner","year":"2024","journal-title":"World J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17476348.2023.2210837","article-title":"Pulmonary recovery after COVID-19\u2014A review","volume":"17","author":"Sonnweber","year":"2023","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.220019","article-title":"Chest CT-based Assessment of 1-year Outcomes after Moderate COVID-19 Pneumonia","volume":"305","author":"Bocchino","year":"2022","journal-title":"Radiology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12931-022-02166-8","article-title":"Lung function and radiological findings 1 year after COVID-19: A prospective follow-up","volume":"23","author":"Tarraso","year":"2022","journal-title":"Respir. Res."},{"key":"ref_14","first-page":"100733","article-title":"Post-COVID-19 respiratory sequelae two years after hospitalization: An ambidirectional study","volume":"33","author":"Lamas","year":"2024","journal-title":"Lancet Reg. Health Am."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Babar, M., Jamil, H., Mehta, N., Moutwakil, A., and Duong, T.Q. (2024). Short- and Long-Term Chest-CT Findings after Recovery from COVID-19: A Systematic Review and Meta-Analysis. Diagnostics, 14.","DOI":"10.3390\/diagnostics14060621"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sharif-Zak, M., Abbasi-Jorjandi, M., Asadikaram, G., Ghoreshi, Z.A., Rezazadeh-Jabalbarzi, M., Afsharipur, A., Rashidinejad, H., Khajepour, F., Jafarzadeh, A., and Arefinia, N. (2022). CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender. Immunobiology, 227.","DOI":"10.1016\/j.imbio.2022.152184"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109325","DOI":"10.1016\/j.intimp.2022.109325","article-title":"Role of CCL2\/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table","volume":"113 (Pt A)","author":"Ranjbar","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/thoraxjnl-2016-208423","article-title":"Pulmonary CCR2(+)CD4(+) T cells are immune regulatory and attenuate lung fibrosis development","volume":"72","author":"Milger","year":"2017","journal-title":"Thorax"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00406-023-01631-9","article-title":"Rehabilitative interventions in patients with persistent post COVID-19 symptoms\u2014A review of recent advances and future perspectives","volume":"274","author":"Gloeckl","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/12\/1954\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:40:38Z","timestamp":1760114438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/12\/1954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":21,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["medicina60121954"],"URL":"https:\/\/doi.org\/10.3390\/medicina60121954","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}